Physician profile
Camilo A Ruiz
NPI 1063664696
$135,854.56
in general payments reported to CMS, 2019-2025
17 companies · $85K in 2025
The $85K reported for 2025 was more than what 98% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,265 · 2020: $4,861 · 2021: $9,290 · 2022: $8,527 · 2023: $26K · 2024: $1,004 · 2025: $85K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $102K · Travel and Lodging: $5,425 · Food and Beverage: $4,271 · Consulting Fee: $350 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $101,774.50 |
| Travel and Lodging | $5,424.72 |
| Food and Beverage | $4,271.33 |
| Consulting Fee | $350.00 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $83,232.97 | 2025 | Zepbound |
| Idorsia Pharmaceuticals US INC | $32,327.65 | 2022-2025 | Quviviq, Quviviq |
| Eisai INC. | $12,761.15 | 2020-2022 | |
| Inspire Medical Systems, INC. | $2,932.49 | 2019-2020 | |
| Harmony Biosciences LLC | $1,336.13 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $1,221.43 | 2019-2025 | |
| Watermark Medical, INC. | $1,172.78 | 2021-2023 | Ares Home Sleep Testing Device |
| Avadel Cns Pharmaceuticals, LLC | $258.67 | 2024-2025 | Lumryz |
| Janssen Biotech, INC. | $146.20 | 2025 | Tremfya |
| Portola Pharmaceuticals, LLC | $126.05 | 2019 | |
| Abbott Laboratories | $78.93 | 2022 | |
| Fisher & Paykel Healthcare INC | $68.70 | 2024-2025 | Fisher & Paykel Healthcare |
| Grifols USA, LLC | $58.64 | 2025 | Prolastin-C Liquid |
| Axsome Therapeutics, INC. | $47.87 | 2024-2025 | Sunosi |
| Medtronic Vascular, INC. | $34.54 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $27.14 | 2019 | |
| Ge Healthcare | $23.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Camilo Ruiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.